Early on, the drug substance (DS) manufacturer will provide a wealth of preliminary characterization data. And if the drug is active in early nonclinical and preclinical testing, a larger quantity of ...

To optimize the final formulation for a drug, it must meet many criteria beyond producing a safe and effective product. For example, it must be stable and amenable to various manufacturing steps, such ...

Self-emulsifying drug delivery systems (SEDDS) are a well-established formulation strategy for improving the oral bioavailability of poorly water-soluble drugs. Traditional development of these ...

High-concentration formulations and patient centricity are challenges to the formulation of biosimilars, which already face patent protection barriers. Biosimilar formulation development requires ...

Scientists have successfully tested the use of machine learning models to guide the design of long-acting injectable drug formulations. The potential for machine learning algorithms to accelerate drug ...

Expertise in CMC (chemistry, manufacturing, and control) ensures the appropriate manufacture of a pharmaceutical or biologic by coordinating material characterization, formulation development, and ...

In the world of drug discovery and clinical trials, drug formulation can make or break a product’s success, yet its role often goes underappreciated, says Christine Allen, cofounder and CEO of ...

This interview addresses the challenges and complexities of developing and manufacturing controlled-release drug formulations. Could you introduce yourself and your expertise in drug development and ...

Intrepid Labs’ Valiant platform uses AI and robotics to cut drug formulation timelines from months to days Over $11M USD total raised to-date; latest round led by AVANT BIO TORONTO--(BUSINESS ...

P-chloroaniline is a polar organochlorine compound and an important member of aromatic amines, widely used in various industries, including pesticides, dyes, and pharmaceuticals. Exposure to high ...

Dec 2 (Reuters) - U.S. drugmaker Merck & Co (MRK.N), opens new tab hopes to patent a new formulation of its $20 billion cancer immunotherapy Keytruda that can be injected under the skin, allowing it ...